[Inhibition of platelet aggregability by ARB].
Fujii
Satoshi
S
Department of Cardiovascular Medicine, Hokkaido University Hospital.
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology* / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D044244:Receptors, Thromboxane A2, Prostaglandin H2 / Q000502:physiology; D013928:Thromboxane A2 / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D010975:Platelet Aggregation Inhibitors; D044244:Receptors, Thromboxane A2, Prostaglandin H2; D013928:Thromboxane A2